Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5282283 | 6276604 | I | 5282283-1 | 20070208 | 20070319 | 20070331 | EXP | GB-PFIZER INC-2007023354 | PFIZER INC | 49 | YR | F | Y | 87 | KG | 20070330 | OT | UNITED KINGDOM |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5282283 | 1008316816 | PS | GABAPENTIN | 1 | ORAL | 020235 | |||||
5282283 | 1008316817 | C | ACETYLSALICYLIC ACID SRT | 1 | |||||||
5282283 | 1008316818 | C | CELECOXIB | 2 | |||||||
5282283 | 1008316819 | C | DIHYDROCODEINE BITARTRATE INJ | 1 | ORAL | ||||||
5282283 | 1008316820 | C | ACETAMINOPHEN | 1 | ORAL | ||||||
5282283 | 1008316821 | C | RABEPRAZOLE SODIUM | 1 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5282283 | 1008316816 | NEURALGIA |
Outcome of event
Event ID | OUTC COD |
---|---|
5282283 | OT |
Reactions reported
Event ID | PT |
---|---|
5282283 | MIGRAINE |
5282283 | OCULAR HYPERAEMIA |
5282283 | PARAESTHESIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5282283 | 1008316816 | 20070207 | 20070217 |